Stanley Druckenmiller acquired 3.07M NewAmsterdam Pharma Company NV shares worth $97.7M. That's 3.00% of their equity portfolio (9th largest holding). The investor owns 2.56% of the outstanding NewAmsterdam Pharma Company NV stock. The stake costed the investor $84.9M, netting the investor a gain of 15% so far.